BMEANasdaqPharmaceutical PreparationsFiscal year ends December 31
Biomea Fusion, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$0.84−0.03 (-3.84%)
Close on Oct 19, 2026
- Market cap
- $60.46M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Biomea Fusion has not reported a dividend
No dividend per share appears in Biomea Fusion's annual filings since fiscal 2018.